23 June 2022 Winston & Strawn LLP To print this article, all you need is to be registered or login on Mondaq.com. On June 8, 2022, the Department of Justice (DOJ), on behalf of itself and the United States Patent and Trademark Office (PTO) as well as the National Institute for Standards and…
22 June 2022 Sheppard Mullin Richter & Hampton To print this article, all you need is to be registered or login on Mondaq.com. Since President Biden’s July 2021 direction to the Federal Trade Commission (“FTC”) to “curtail the unfair use of non-compete clauses and other clauses or agreements that may unfairly limit worker…
20 June 2022 Erso Capital Advisors LLC To print this article, all you need is to be registered or login on Mondaq.com. In the Competition Appeal Tribunal, claimant and defendant arguments around the grant, nature and scope of a Collective Proceedings Order (“CPO”) are developing quickly. The issues around opt-in and opt-out seen…
03 June 2022 Goodwin Procter LLP To print this article, all you need is to be registered or login on Mondaq.com. Late last week, Regeneron Pharmaceuticals, Inc. filed an antitrust complaint against Amgen Inc. in the US District Court for the District of Delaware. Regeneron alleges that “Amgen is engaged in a persistent…
On 25 May 2022 the Supreme Court overturned the Court of Appeal’s ruling on costs in Pfizer and Flynn Pharma and concluded that the Competition Appeal Tribunal (CAT) had applied the correct test when awarding a proportion of their costs against the CMA. The Court of Appeal had held that, despite Pfizer and Flynn’s successful…
